DelveInsight’s, “Squamous Cell Carcinoma Pipeline Insight” report provides comprehensive insights about 75+ companies and 80+ ...

McDermott says that he started seeing a dermatologist when he was in his 20s at the recommendation of his parents.

Rakuten Medical initiates global phase 3 trial of ASP-1929 photoimmunotherapy in combo with pembrolizumab to treat recurrent head and neck cancer: United States Saturday, January ...

Sintilimab plus neoadjuvant CRT improved pathological complete response rates in resectable, locally advanced ESCC, per phase ...

The phase 3 RATIONALE-306 study found no significant difference in overall survival benefits from tislelizumab plus ...

The trial builds off the company’s previous Phase Ia/II trial that saw an estimated survival rate of 52.4% at 24 months in ...

In patients with advanced ESCC treated with first-line tislelizumab plus chemotherapy, deeper responses and longer time to ...

Eldiara Doucette, a TikTok star who details her journey with rare cancer synovial sarcoma online, shared a lighthearted ...

People taking metformin had a lower risk of the two most common skin cancers However, Black patients were not protected against squamous cell cancer TUESDAY, Jan. 14, 2025 (HealthDay News) -- A ...

as opposed to 1.5% in the placebo arm. Two patients in each study group developed complications leading to death. These findings underline Libtayo’s “potential to also transform the treatment of ...

Those with squamous cell cancer of the anus were offered radiation ... DNA copy number change was gain mapped to chromosome arm 3q (12% of AIN 2 and 33% of AIN 3). This alteration was previously ...

The NavDx test demonstrates high performance in detecting recurrent disease, providing an enhanced and widely accessible surveillance tool for HPV+ anal squamous cell carcinoma patients WALTHAM, Mass.